New Web Site Fills Need for Reliable Cancer Information

Publication
Article
OncologyONCOLOGY Vol 13 No 2
Volume 13
Issue 2

The University of Michigan (U-M) Comprehensive Cancer Center has launched an Internet site to serve the growing online community of cancer patients seeking trustworthy medical information. The web site, which is located at

The University of Michigan (U-M) Comprehensive Cancer Center has launched an Internet site to serve the growing online community of cancer patients seeking trustworthy medical information. The web site, which is located at www.cancer.med.umich.edu, features information on University of Michigan cancer research and patient care services that previously was difficult to access from home.

“We can now offer the public access to our clinical trials database, which includes easy-to-understand descriptions of more than 100 investigational treatments for nearly every type

and stage of cancer,” says Max S.Wicha, MD, breast oncologist and director of the cancer center. “Physicians in the community will find this database a valuable resource for referring their patients to cancer center clinical trials.”

In another section, current and prospective patients can learn about the cancer center’s history and current happenings. The “Learn About Cancer” section contains information about specific cancers, treatments and side effects, nutrition, clinical trials, and support groups. In addition, the site provides links to hundreds of cancer-related web sites that have been screened and approved by University of Michigan physicians

“Our web site also allows anyone to send an e-mail message to U-M’s Cancer AnswerLine nurses, who give personalized answers to cancer care questions and refer patients to appropriate U-M physicians,” Dr. Wicha says.

Cancer center patients will find the site’s “Guide for Patients” useful. It helps them understand what they can expect during their visit, gives them phone numbers they might need, and provides maps to the University of Michigan Health System. All of the cancer center’s publications can be found online as well. Another section of the site, “Share the Hope and Humor,” which is spearheaded by a cancer survivor, offers inspirational stories, thoughts and images—and invites visitors to contribute their personal insights.

For health professionals, the site offers a section devoted to updates on research projects, continuing medical education opportunities, and a referral guide.

Recent Videos
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
2 experts are featured in this series.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Related Content